Oxytetracycline hydrochloride: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Oxytetracycline hydrochloride }} '''''For patient information, click <u>here'''''</u>. {{CMG}}; {{AE}} {{..." |
|||
| Line 14: | Line 14: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
'''| [[Oxytetracycline hydrochloride indications and usage|Indications and Usage]]''' | '''| [[Oxytetracycline hydrochloride indications and usage|Indications and Usage]]''' | ||
'''| [[Oxytetracycline hydrochloride contraindications|Contraindications]]''' | '''| [[Oxytetracycline hydrochloride contraindications|Contraindications]]''' | ||
'''| [[Oxytetracycline hydrochloride warnings and precautions|Warnings and Precautions]]''' | '''| [[Oxytetracycline hydrochloride warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Oxytetracycline hydrochloride adverse reactions|Adverse Reactions]]''' | '''| [[Oxytetracycline hydrochloride adverse reactions|Adverse Reactions]]''' | ||
'''| [[Oxytetracycline hydrochloride dosage and administration|Dosage and Administration]]''' | '''| [[Oxytetracycline hydrochloride dosage and administration|Dosage and Administration]]''' | ||
'''| [[Oxytetracycline hydrochloride how supplied|How Supplied]]''' | '''| [[Oxytetracycline hydrochloride how supplied|How Supplied]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 06:31, 9 January 2014
| Oxytetracycline hydrochloride |
|---|
| UROBIOTIC® FDA Package Insert |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
UROBIOTIC®
FDA Package Insert
| Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied
Mechanism of Action
The tetracyclines are primarily bacteriostatic and are thought to exert their antimicrobial effect by the inhibition of protein synthesis. The tetracyclines, including minocycline, have a similar antimicrobial spectrum of activity against a wide range of gram-positive and gram-negative organisms. Cross-resistance of these organisms to tetracyclines is common. [1]
References
- ↑ "DYNACIN (Oxytetracycline hydrochloride ) CAPSULE [MEDICIS, THE DERMATOLOGY COMPANY]". Text " accessdate" ignored (help)